FDA Highlights Shortfalls At COVID-19 Vaccine Plant
The U.S. Food and Drug Administration said Wednesday that it found numerous shortcomings at an Emergent BioSolutions plant in Maryland that had been producing COVID-19 vaccines for Johnson & Johnson, including unclean...To view the full article, register now.
Already a subscriber? Click here to view full article